NCT06914999
PET/CT Assessment of Radiation-Induced Vascular Complications in Head and Neck Cancer
At risk: Primary completion moved 12 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Aug 31, 2026 to Aug 31, 2027 Show 5 more changesShow less
- Eligibility criteria expanded, about 18 words
- Study completion pushed from Aug 31, 2027 to Aug 31, 2028
- Secondary endpoints: details revised at 1 of 1 entry
- Site contact updated
- Study title shortened, about 18 words
- Notable Primary completion date: Aug 31, 2025 to Aug 31, 2026
- Study completion date: Aug 31, 2026 to Aug 31, 2027
- Site contact updated
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (1)
Arms and interventions
Patients receive F-18 NaF IV and undergo PET/CT within 28 days of each SOC F-18 FDG PET/CT on study, once prior to initiation of SOC IMRT and once 12 weeks after completion of SOC IMRT.
Patients receive F-18 NaF IV and undergo PET/CT within 28 days of each SOC F-18 FDG PET/CT on study, once prior to initiation of SOC IMPT and once 12 weeks after completion of SOC IMPT.
Procedures: Computed Tomography, Intensity-Modulated Proton Therapy, Positron Emission Tomography
Other: Fludeoxyglucose F-18
Radiation: Intensity-Modulated Radiation Therapy
Drugs: Sodium Fluoride F-18
Sites
1 site in 1 country
- Emory University Hospital MidtownAtlanta, Georgia, United States